Not yet taking people in ItalyPhase 4
Studying heart rate and quality of life in a heart disease caused by amyloid
Studies a treatment for adults with a heart disease caused by protein deposits.
Key facts
- Who runs it
- Universita' Degli Studi Di Genova
- Where
- Firenze, Genova, and Roma, ItalySee the 3 sites
- Trial code
- Registry title
- HeArt Rate and quality of Life in transthyrEtin cardiac amYloidosis (HARLEY)
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 104 people, planned
- Started
- 13 Jan 2025
- Expected to end
- 31 Jan 2027
- Type of study
- Interventional
- Record updated
- 27 May 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with transthyretin cardiac amyloidosis. The record gives no further details.
- Age
- 18 years or older
- Sex
- All sexes
Main reasons for not taking part
- Healthy volunteers cannot join.
Where in Italy
- Azienda Ospedaliera Universitaria CareggiFirenze, ItalyNot yet recruiting
- Ircss Ospedale Policlinico San MartinoGenova, ItalyNot yet recruiting
- Università Sapienza, Azienda Ospedaliera Sant’AndreaRoma, ItalyNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Studying heart rate and quality of life in a heart disease caused by amyloidGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 27 May 2025